Pharmacology & ToxicologybioRxiv
Discovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L
I. Meewan, J. Kattoula, J. Kattoula…·R. Abagyan
This paper identifies potent triple inhibitors targeting SARS-CoV-2 proteases and human cathepsin L, showing improved potency and antiviral effects compared to disulfiram.
DOI 10.3390/ph15060744